Sg Americas Securities, LLC Axsome Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

  • $30.5 Billion
  • Q1 2025

A detailed history of Sg Americas Securities, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 2,751 shares of AXSM stock, worth $302,389. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,751
Previous 3,552 22.55%
Holding current value
$302,389
Previous $301,000 6.64%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 15, 2025
SELL
$80.05 - $137.75 $64,120 - $110,337
-801 Reduced 22.55%
2,751 $321,000
Q4 2024

Jan 17, 2025
SELL
$83.08 - $100.49 $664,723 - $804,020
-8,001 Reduced 69.25%
3,552 $301,000
Q3 2024

Oct 03, 2024
BUY
$78.93 - $95.84 $911,878 - $1.11 Million
11,553 New
11,553 $1.04 Million
Q1 2024

May 06, 2024
BUY
$69.39 - $97.64 $899,502 - $1.27 Million
12,963 Added 605.46%
15,104 $1.21 Million
Q4 2023

Jan 12, 2024
BUY
$57.42 - $83.61 $122,936 - $179,009
2,141 New
2,141 $170,000
Q1 2023

Apr 28, 2023
BUY
$58.39 - $75.0 $675,046 - $867,075
11,561 Added 676.87%
13,269 $818,000
Q4 2022

Feb 02, 2023
SELL
$39.94 - $79.72 $485,430 - $968,916
-12,154 Reduced 87.68%
1,708 $132,000
Q3 2022

Oct 31, 2022
BUY
$36.06 - $69.85 $195,156 - $378,028
5,412 Added 64.05%
13,862 $619,000
Q2 2022

Jul 29, 2022
SELL
$21.74 - $46.75 $516,542 - $1.11 Million
-23,760 Reduced 73.77%
8,450 $324,000
Q1 2022

Apr 29, 2022
SELL
$23.7 - $41.39 $24,482 - $42,755
-1,033 Reduced 3.11%
32,210 $1.33 Million
Q4 2021

Feb 07, 2022
SELL
$30.7 - $43.36 $1.53 Million - $2.16 Million
-49,823 Reduced 59.98%
33,243 $1.26 Million
Q3 2021

Nov 01, 2021
BUY
$19.91 - $68.26 $787,619 - $2.7 Million
39,559 Added 90.93%
83,066 $2.74 Million
Q2 2021

Aug 12, 2021
SELL
$50.63 - $73.5 $548,981 - $796,960
-10,843 Reduced 19.95%
43,507 $2.94 Million
Q1 2021

May 13, 2021
BUY
$55.91 - $81.44 $118,473 - $172,571
2,119 Added 4.06%
54,350 $3.08 Million
Q4 2020

Feb 04, 2021
BUY
$66.31 - $86.52 $2.15 Million - $2.81 Million
32,423 Added 163.69%
52,231 $4.26 Million
Q3 2020

Nov 09, 2020
BUY
$68.34 - $85.84 $363,500 - $456,582
5,319 Added 36.71%
19,808 $1.41 Million
Q2 2020

Jul 20, 2020
BUY
$49.87 - $98.69 $127,617 - $252,547
2,559 Added 21.45%
14,489 $1.19 Million
Q1 2020

Apr 30, 2020
BUY
$41.2 - $101.31 $282,796 - $695,391
6,864 Added 135.49%
11,930 $702,000
Q4 2019

Jan 28, 2020
BUY
$16.71 - $106.24 $84,652 - $538,211
5,066 New
5,066 $524,000
Q3 2019

Nov 04, 2019
SELL
$20.24 - $29.16 $131,114 - $188,898
-6,478 Closed
0 $0
Q2 2019

Jul 29, 2019
BUY
$13.46 - $25.75 $87,193 - $166,808
6,478 New
6,478 $167,000

Others Institutions Holding AXSM

# of Institutions
358
Shares Held
36.4M
Call Options Held
1.77M
Put Options Held
1.16M
View Full List

About Axsome Therapeutics, Inc.

AXSM Quotes by TradingView
  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $4.71B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email